Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hammerberg

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
The Journal of Investigative Dermatology|March 25, 2000
Overexpression of the oncofetal Fn variant containing the EDA splice-in segment in the dermal-epidermal junction of psoriatic uninvolved skinK M Ting, D Rothaupt, T S McCormick, et al.
The Journal of Clinical Investigation|August 1, 1992
Interleukin-1 receptor antagonist in normal and psoriatic epidermisC Hammerberg, W P Arend, G J Fisher, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epitheliumS Haskill, G Martin, L Van Le, et al.
The Journal of Investigative Dermatology|September 1, 1990
UM4D4+ (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesionsO Baadsgaard, P Tong, J T Elder, et al.
The Journal of Investigative Dermatology|May 1, 1991
Cellular, immunologic and biochemical characterization of topical retinoic acid-treated human skinG J Fisher, J Esmann, C E Griffiths, et al.
The British Journal of Dermatology|March 31, 2012
Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24F Wang, N Smith, L Maier, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
The Journal of Investigative Dermatology|March 25, 2000
Overexpression of the oncofetal Fn variant containing the EDA splice-in segment in the dermal-epidermal junction of psoriatic uninvolved skinK M Ting, D Rothaupt, T S McCormick, et al.
The Journal of Clinical Investigation|August 1, 1992
Interleukin-1 receptor antagonist in normal and psoriatic epidermisC Hammerberg, W P Arend, G J Fisher, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epitheliumS Haskill, G Martin, L Van Le, et al.
The Journal of Investigative Dermatology|September 1, 1990
UM4D4+ (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesionsO Baadsgaard, P Tong, J T Elder, et al.
The Journal of Investigative Dermatology|May 1, 1991
Cellular, immunologic and biochemical characterization of topical retinoic acid-treated human skinG J Fisher, J Esmann, C E Griffiths, et al.
The British Journal of Dermatology|March 31, 2012
Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24F Wang, N Smith, L Maier, et al.
Pageof 7